Literature DB >> 7054619

Experimental animal endocarditis.

A J Wright, W R Wilson.   

Abstract

The results of studies performed with animal models of experimental infective endocarditis have provided valuable information about the pathophysiology, natural history, and treatment of this infection. The Freedman rabbit model of experimental infective endocarditis is relatively simple to perform, is reproducible, and with minor modifications has become the standard model for the study of experimental endocarditis. The following are the major advantages of the Freedman model: (1) its relatively low cost and simplicity permit the study of large numbers of animals required for statistical analysis of results; (2) the model enables accurate control of the timing of the onset of infection, the administration of antimicrobial agents, and the duration of infection and treatment before the animal is killed; and (3) the experimental infection in rabbits histologically resembles the pathologic changes that occur in this infection in humans. This model has some disadvantages: (1) the artificially induced trauma to rabbit cardiac valves is different pathophysiologically from the conditions that predispose humans to infective endocarditis; (2) a larger inoculum of bacteria is required to produce infections in rabbits than that which causes human endocarditis; and (3) the rabbit model is a more severe, acute form of infection than human infective endocarditis, and survival of untreated animals for longer than 2 weeks is unusual. One should exercise considerable caution in extrapolating the results obtained from animal experimental infective endocarditis to human infection.

Entities:  

Mesh:

Year:  1982        PMID: 7054619

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

1.  ADP-like platelet aggregation activity generated by viridans streptococci incubated with exogenous ATP.

Authors:  M C Herzberg; K L Brintzenhofe
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

2.  Bacterial adherence to human endothelial cells in vitro.

Authors:  S K Ogawa; E R Yurberg; V B Hatcher; M A Levitt; F D Lowy
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

3.  Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.

Authors:  R W Strunk; J C Gratz; R Maserati; W M Scheld
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.